doi: 10.3389/fnins.2024.1451740 Received 17 September 2024 Accepted 20 December 2024 Published 10 January 2025 Volume 18 - 2024 Edited by Jeronimo Jurado Arjona, Kings College London, United Kingdom Reviewed by Rheinallt Parri, Aston University, United Kingdom Marco I
Self-administration of either compound without medical supervision represents a significant and unquantified health risk
Atherosclerosis is associated with impairment of vascular endothelial function, thereby compromising vasodilation and normal blood flow
What is the risk of serotonin syndrome in patients taking a combination of GLP-1 (Glucagon-like peptide-1) receptor agonists, SSRIs (Selective Serotonin Reuptake Inhibitors), and ADHD (Attention Deficit Hyperactivity Disorder) medications?
These resources have led to refinement of BC classification in four molecular subtypes, i.e., Luminal A, Luminal B, HER2, and Basal